Metraipolis › archive › dc_7662dec62716

Are patient factors associated with real-world antibody-drug conjugate outcomes in gynecologic cancers? — Europe PMC PMID:42054783

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42054783
DOI
10.1016/j.ygyno.2026.04.011
License (as archived)
solo-consultazione
Archived
2026-11-03T03:33:32.382Z
SHA-256 of the archived text
a1faee0e2ac6225473bd5a3615802d8f95c7e054c6d57325d4f139526ddf12ca
Stable URL of this page
https://metraipolis.com/documento/dc_7662dec62716

How to cite

Are patient factors associated with real-world antibody-drug conjugate outcomes in gynecologic cancers? — Europe PMC PMID:42054783 — Europe PMC (en), https://europepmc.org/article/MED/42054783 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7662dec62716 (Metraipolis archive dc_7662dec62716, sha256 a1faee0e2ac6225473bd5a3615802d8f95c7e054c6d57325d4f139526ddf12ca)
BibTeX
@misc{dc7662dec62716,
  title = {Are patient factors associated with real-world antibody-drug conjugate outcomes in gynecologic cancers? — Europe PMC PMID:42054783},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42054783},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7662dec62716; sha256 a1faee0e2ac6225473bd5a3615802d8f95c7e054c6d57325d4f139526ddf12ca},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42054783. Agents can read the archived copy with the MCP tool read_document.